Tokyo-headquartered Elix, an AI drug discovery company with the mission of 'Rethinking Drug Discovery' launched Elix Discovery, the only all-in-one platform that provides everything needed for AI drug discovery, from models for property prediction and molecular design to AI consulting and implementation support.

Elix Discovery is the only all-in-one platform that provides a wide selection of AI models, intuitive Graphical User Interface (GUI), expert implementation support and consulting, and knowledge for AI drug discovery. The platform provides essential features for AI drug discovery, and will continue to grow from ongoing updates as new developments are made in the ever-evolving AI field. While many AI companies are secretive and do not disclose their knowledge and methods to clients, Elix, values transparency and openly shares knowledge with our clients to help them accumulate experience in AI drug discovery.

Key modules of Elix Discovery

Elix Predict (property prediction): By inputting the chemical compound structure into AI models, key information about the compound can be predicted, such as activity against a target, physicochemical properties, and ADMET properties.

Elix Create (molecular design): Generative AI models make it possible to algorithmically create compounds with desired properties. Molecules can be optimised for a number of factors, including target activity, physicochemical properties, ADMET, and ease of synthesis. Predictive models from Elix Predict can also be easily used for molecular optimisation thanks to integrated design of Elix Discovery.

3. Elix Assist (active learning): A suite of methods for efficiently training AI models when there is little or no available experimental data. Active learning based on predictive AI models is used to suggest the compounds that should be used to collect the next set of experimental data based on an optimisation algorithm, thereby enabling the training of high performing models with fewer experiments.